Stock Screener
| # | Symbol | Price | Change % | Market Cap▼ | Volume | Name | 1 Week % | 1 Month % | 3 Month % | 6 Month % | 1 Year % | Equity Type | Industry |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 101 | TRVI | 13.98 | +3.51 | 2.0B | 1.2M | Trevi Therapeutics, Inc. Common Stock | +2.67 | +17.51 | -25.66 | +5.62 | +26.66 | Common Stock | Biotechnology |
| 102 | FTRE | 20.25 | -1.21 | 2.0B | 566.9K | Fortrea Holdings Inc. Common Stock | +0.96 | -9.67 | +11.64 | +47.72 | +101.71 | Common Stock | Biotechnology |
| 103 | IMNM | 16.55 | -1.39 | 2.0B | 419.8K | Immunome, Inc. | -11.51 | -1.33 | -44.52 | -15.83 | -6.46 | Common Stock | Biotechnology |
| 104 | HRMY | 32.71 | -1.21 | 1.9B | 409.3K | Harmony Biosciences Holdings, Inc. Common Stock | -3.23 | -12.87 | -18.08 | +7.46 | -1.80 | Common Stock | Biotechnology |
| 105 | VERA | 26.46 | +3.46 | 1.9B | 613.3K | Vera Therapeutics, Inc. Class A Common Stock | -8.87 | -8.49 | -18.00 | -20.41 | -7.31 | Common Stock | Biotechnology |
| 106 | ZYME | 26.91 | +3.35 | 1.9B | 546.3K | Zymeworks Inc. | +1.67 | +5.37 | -1.10 | +10.29 | +19.08 | Common Stock | Biotechnology |
| 107 | BCRX | 7.29 | -0.09 | 1.9B | 2.1M | BioCryst Pharmaceuticals Inc | -5.03 | -9.62 | -27.57 | -16.84 | +5.25 | Common Stock | Biotechnology |
| 108 | REPL | 19.37 | -2.20 | 1.8B | 998.5K | Replimune Group, Inc. | -11.86 | +75.33 | +30.81 | +312.20 | +115.50 | Common Stock | Biotechnology |
| 109 | STOK | 26.89 | +0.75 | 1.8B | 264.7K | Stoke Therapeutics, Inc. Common Stock | +2.63 | +8.34 | -18.59 | -10.25 | -5.58 | Common Stock | Biotechnology |
| 110 | RARE | 17.24 | -2.78 | 1.8B | 1.3M | Ultragenyx Pharmaceutical Inc. | +5.95 | +14.38 | -34.31 | -23.22 | -45.90 | Common Stock | Biotechnology |
| 111 | AGIO | 28.93 | -2.51 | 1.7B | 229.4K | Agios Pharmaceuticals, Inc. | -8.89 | -17.09 | -17.61 | +4.34 | +29.52 | Common Stock | Biotechnology |
| 112 | RXRX | 2.69 | -4.60 | 1.7B | 32.8M | Recursion Pharmaceuticals, Inc. Class A Common Stock | -19.07 | -25.35 | -23.00 | -5.44 | -33.13 | Common Stock | Biotechnology |
| 113 | VIR | 8.95 | -2.18 | 1.7B | 1.1M | Vir Biotechnology, Inc. Common Stock | -26.15 | -12.33 | -8.38 | +4.93 | +64.54 | Common Stock | Biotechnology |
| 114 | URGN | 31.80 | +6.73 | 1.6B | 1.3M | UroGen Pharma Ltd. | +20.48 | -6.89 | -36.77 | +12.51 | +25.82 | Common Stock | Biotechnology |
| 115 | SRPT | 14.13 | -2.73 | 1.5B | 1.2M | Sarepta Therapeutics,, Inc. Common Stock | -11.72 | -20.29 | -28.37 | -15.06 | -13.77 | Common Stock | Biotechnology |
| 116 | NRIX | 13.63 | -3.31 | 1.5B | 1.1M | Nurix Therapeutics, Inc. Common stock | -12.60 | -45.31 | -50.94 | -10.54 | -4.86 | Common Stock | Biotechnology |
| 117 | PGEN | 4.12 | -3.63 | 1.5B | 2.9M | Precigen, Inc. Common Stock | -11.70 | -38.21 | -42.53 | -1.08 | -2.49 | Common Stock | Biotechnology |
| 118 | MESO | 11.16 | -4.08 | 1.4B | 199.6K | Mesoblast Limited | -14.77 | -6.57 | -34.82 | -23.27 | -24.82 | ADR | Biotechnology |
| 119 | ANAB | 47.51 | +0.95 | 1.4B | 282.1K | AnaptysBio, Inc. Common Stock | -0.56 | -3.52 | -19.84 | -20.52 | +28.36 | Common Stock | Biotechnology |
| 120 | QURE | 20.11 | -0.94 | 1.4B | 593.0K | uniQure N.V. | -18.35 | -9.41 | -58.76 | -18.55 | -28.05 | Common Stock | Biotechnology |